Cargando…

PsoBarrier EU study: a Multicentre, Cross-sectional Survey Investigating the Quality of Psoriasis Care in Four European Countries

Enhanced treatment options for psoriasis and growing use of guidelines increased the potential to better quality of psoriasis care in Europe. The aim of the PsoBarrier EU study is to compare the quality and processes of psoriasis care in four European countries with different healthcare systems, bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	LANGENBRUCH, Anna, MOHR, Nicole, ANDREES, Valerie, KESSENS, Ihno, REICH, Adam, CZARNECKA-OPERACZ, Magdalena, PUIG, Luis, DAUDEN, Esteban, IVERSEN, Lars, AUGUSTIN, Matthias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:	Original Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496845/ https://www.ncbi.nlm.nih.gov/pubmed/37649411 http://dx.doi.org/10.2340/actadv.v103.6532

Ejemplares similares

Nail psoriasis as a severity indicator: results from the PsoReal study
por: Radtke, Marc A, et al.
Publicado: (2010)

Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire
por: Dauden, Esteban, et al.
Publicado: (2012)

Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest
por: Reich, K., et al.
Publicado: (2015)

Regional variations and prevalence of psoriasis in Germany from 2010 to 2017: a cross-sectional, spatio-epidemiological study on ambulatory claims data
por: Andrees, Valerie, et al.
Publicado: (2021)

The possibilities and principles of methotrexate treatment of psoriasis – the updated knowledge
por: Czarnecka-Operacz, Magdalena, et al.
Publicado: (2014)

Quo vadis, biological treatment for psoriasis and psoriatic arthritis?
por: Olszewska, Barbara, et al.
Publicado: (2018)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations
por: Augustin, Jobst, et al.
Publicado: (2022)

Psoriasis pathogenesis – Pso p27 constitutes a compact structure forming large aggregates
por: Lysvand, Hilde, et al.
Publicado: (2015)

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study—IL PSO (Italian landscape psoriasis)
por: Narcisi, Alessandra, et al.
Publicado: (2022)

Low Pneumococcal Vaccination among Patients with Psoriasis in Germany: Results from Vac-Pso
por: Wellmann, Phoebe, et al.
Publicado: (2022)

Generalized Pustular Psoriasis: A Review on Clinical Characteristics, Diagnosis, and Treatment
por: Rivera-Díaz, Raquel, et al.
Publicado: (2023)

Implementation of the PsoWell™ Model for the Management of People with Complex Psoriasis
por: HEWITT, Rachael M., et al.
Publicado: (2021)

Psoriasis Therapy and Skin Cancer: A Review
por: Butrón-Bris, Beatriz, et al.
Publicado: (2021)

Association Between Patient- and Physician-Reported Outcomes in Patients with Moderate-To-Severe Plaque Psoriasis Treated with Biologics in Real Life (PSO-BIO-REAL)
por: Lacour, Jean-Philippe, et al.
Publicado: (2020)

Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis
por: Jenerowicz, Dorota, et al.
Publicado: (2020)

Secukinumab efficacy in reducing the severity and the psychosocial impact of moderate‐to‐severe psoriasis as assessed by the Simplified Psoriasis Index: results from the IPSI‐PSO study
por: Richard, M.‐A., et al.
Publicado: (2020)

Recall of health-related quality of life: how does memory affect the SF-6D in patients with psoriasis or multiple sclerosis? A prospective observational study in Germany
por: Topp, Janine, et al.
Publicado: (2019)

Calcipotriol Plus Betamethasone Dipropionate Aerosol Foam in Patients with Moderate-to-Severe Psoriasis: Sub-Group Analysis of the PSO-ABLE Study
por: Paul, Carle, et al.
Publicado: (2017)

Genetics of Psoriasis and Pharmacogenetics of Biological Drugs
por: Prieto-Pérez, Rocío, et al.
Publicado: (2013)

Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial
por: Katsambas, Andreas, et al.
Publicado: (2009)

A multinational, prospective, observational study to estimate complete skin clearance in patients with moderate‐to‐severe plaque PSOriasis treated with BIOlogics in a REAL world setting (PSO‐BIO‐REAL)
por: Seneschal, J., et al.
Publicado: (2020)

Pharmacogenetics Update on Biologic Therapy in Psoriasis
por: Muñoz-Aceituno, Ester, et al.
Publicado: (2020)

Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Quality-of-Life Outcomes, Effectiveness and Tolerability of Apremilast in Patients with Plaque Psoriasis and Routine German Dermatology Care: Results from LAPIS-PSO
por: Reich, Kristian, et al.
Publicado: (2021)

CoronaBest und PsoBest Bioscience: Neue Ausbaustufen beim Deutschen Psoriasis-Register
por: Gehoff, Mario
Publicado: (2020)

Recalcitrant annular pustular psoriasis associated with psoriatic arthritis successfully treated with secukinumab
por: Herrero-Moyano, María, et al.
Publicado: (2018)

Exploring the Association Between History of Psoriasis (PSO) and Disease Activity in Patients with Psoriatic Arthritis (PsA)
por: Li, Shan-Shan, et al.
Publicado: (2022)

Real-world effectiveness of anti-interleukin-23 antibodies in chronic plaque-type psoriasis of patients from the Austrian Psoriasis Registry (PsoRA)
por: Graier, T., et al.
Publicado: (2022)

Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients
por: Wyrzykowska, Nina, et al.
Publicado: (2015)

AdPSO: Adaptive PSO-Based Task Scheduling Approach for Cloud Computing
por: Nabi, Said, et al.
Publicado: (2022)

Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
por: Belinchón Romero, Isabel, et al.
Publicado: (2021)

Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis)
por: Gargiulo, Luigi, et al.
Publicado: (2023)

Particle swarm optimization (PSO)
por: Walker, Brian
Publicado: (2017)

Comparative Effectiveness of Biologics Across Subgroups of Patients with Moderate-to-Severe Plaque Psoriasis: Results at Week 12 from the PSoHO Study in a Real-World Setting
por: Lynde, Charles, et al.
Publicado: (2022)

Definition of treatment goals for moderate to severe psoriasis: a European consensus
por: Mrowietz, U., et al.
Publicado: (2010)

Structure and function of the epidermal barrier in patients with atopic dermatitis – treatment options. Part one
por: Pelc, Jagoda, et al.
Publicado: (2018)

The structure and function of the epidermal barrier in patients with atopic dermatitis – treatment options. Part two
por: Pelc, Jagoda, et al.
Publicado: (2018)

Comparative effectiveness of biologics for patients with moderate-to-severe psoriasis and special area involvement: week 12 results from the observational Psoriasis Study of Health Outcomes (PSoHO)
por: Piaserico, Stefano, et al.
Publicado: (2023)

Evolution of Drug Survival with Biological Agents and Apremilast Between 2012 and 2018 in Patients with Psoriasis from the PsoBioTeq Cohort
por: BETTUZZI, Thomas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d1u2fq93qefm8vgb6fr5d2iqr9